# A Study on the Treatment of Parkinson's Disease With Autologous Neural Stem Cells

> **NCT03815071** · EARLY_PHASE1 · UNKNOWN · sponsor: **Allife Medical Science and Technology Co., Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Ips-nsc cells

## Key facts

- **NCT ID:** NCT03815071
- **Lead sponsor:** Allife Medical Science and Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2020-02-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2019-01-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03815071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03815071, "A Study on the Treatment of Parkinson's Disease With Autologous Neural Stem Cells". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03815071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*